Overview
Congenital temporomandibular joint (TMJ) ankylosis is a rare craniofacial condition present at birth in which the temporomandibular joint is fused or immobile due to bony or fibrous union between the mandibular condyle and the temporal bone. This fusion restricts or completely prevents mouth opening (trismus), leading to significant difficulties with feeding, speech development, oral hygiene, and dental care from the neonatal period onward. The condition affects the musculoskeletal system of the jaw and can lead to secondary deformities including facial asymmetry, micrognathia (small jaw), and malocclusion. If bilateral, it may cause severe airway compromise in neonates due to mandibular hypoplasia and posterior displacement of the tongue. Growth disturbances of the mandible are common, as the fused joint impairs normal condylar growth, resulting in progressive facial deformity during childhood. The etiology of congenital TMJ ankylosis is not fully understood but may be related to intrauterine trauma, forceps delivery, or developmental abnormalities of the joint. It must be distinguished from acquired TMJ ankylosis, which results from postnatal trauma or infection. Treatment is primarily surgical and aims to restore jaw mobility and promote normal mandibular growth. Surgical approaches include gap arthroplasty, interpositional arthroplasty, or joint reconstruction using costochondral grafts. Early surgical intervention is recommended to minimize growth disturbances and functional impairment. Postoperative physiotherapy with aggressive jaw-opening exercises is essential to prevent re-ankylosis, which remains a significant complication. Long-term orthodontic management and possible orthognathic surgery may be needed to address residual facial asymmetry and dental malocclusion.
Also known as:
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsIstanbul Medipol University Hospital
Azienda Ospedaliera di Perugia — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Congenital temporomandibular joint ankylosis.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital temporomandibular joint ankylosis.
Community
No community posts yet. Be the first to share your experience with Congenital temporomandibular joint ankylosis.
Start the conversation →Latest news about Congenital temporomandibular joint ankylosis
Disease timeline:
New recruiting trial: Effects of the Application of a Hyper-oxygenated Gel After Oral Surgery
A new clinical trial is recruiting patients for Congenital temporomandibular joint ankylosis
New recruiting trial: Preoperative Anxiety and Its Impact on Intraoperative Hemodynamics and Postoperative Pain, Edema, and Trismus in Orthognathic Surgery
A new clinical trial is recruiting patients for Congenital temporomandibular joint ankylosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital temporomandibular joint ankylosis
What is Congenital temporomandibular joint ankylosis?
Congenital temporomandibular joint (TMJ) ankylosis is a rare craniofacial condition present at birth in which the temporomandibular joint is fused or immobile due to bony or fibrous union between the mandibular condyle and the temporal bone. This fusion restricts or completely prevents mouth opening (trismus), leading to significant difficulties with feeding, speech development, oral hygiene, and dental care from the neonatal period onward. The condition affects the musculoskeletal system of the jaw and can lead to secondary deformities including facial asymmetry, micrognathia (small jaw), and
At what age does Congenital temporomandibular joint ankylosis typically begin?
Typical onset of Congenital temporomandibular joint ankylosis is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Congenital temporomandibular joint ankylosis?
Yes — 1 recruiting clinical trial is currently listed for Congenital temporomandibular joint ankylosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Congenital temporomandibular joint ankylosis?
2 specialists and care centers treating Congenital temporomandibular joint ankylosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.